ARCHIVES

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

Cancer Meetings Listed

November 1, 1996

Yarbro-Chabner Debate Continues

April 29, 1983

A Misdirected Email: CPRIT Official Speaks of “New Regime” As Institute Denies Deepening Crisis

October 19, 2012

Home Test Detects Hematuria Earlier

August 4, 1989

Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned

March 17, 1995

Also Stillman named director, Cold Spring Harbor, Watson is chancellor.

December 12, 2003